Skip to content

Effect Of Amalakyadi Kwath in Urinary Tract Infection.

A Controlled Phase 2 Clinical Study To Evaluate The Efficacy Of Amalakyadi Kwath In Mutrakruchhra With Special Reference To Urinary Tract Infection.

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039665
Enrollment
70
Registered
2022-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

None listed

Sponsors

PRITEE SANJAY SHEJWAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients fulfilling diagnostic criteria and signs and symptoms of Mutrakruchhra such as: Cloudy or foul smelling urine. Sadaha Mutrapravrutti: Burning Micturation Sashool Mutrapravrutti: Painful Micturation Muhurmuhu Mutrapravrutti: Frequency of Micturation Patients those willing to participate in the study..

Exclusion criteria

Exclusion criteria: Patients not willing for trial. Patients having age below 18and above 60 Patient with catheter urinary stent on haemodialysis organ transplantation Urinary tract diseases like Pyonephrosis AGN Known renal TB Urethral stricture Acute Pylonephritis Radiation for pelvic trauma Prostate cancer Urinary tract malignancy Uncontrolled Diabetes mellitus type 1 and 2 All of the above patients will not be included in the study

Design outcomes

Primary

MeasureTime frame
REDUCTION IN SIGN AND SYMPTOMS OF URINARY TRACT INFECTIONTimepoint: 10 days

Secondary

MeasureTime frame
COST EFFECTIVE , EASY TO PREPARE, EASILY AVAILABLETimepoint: 10 DAYS

Countries

India

Contacts

Public ContactDr Vinay Sonambekar

AYURVED SEVA SANGHA, AYURVED MAHAVIDYALAYA

sonambekar.chinmay@gmail.com9130004890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026